Gauff and Rybakina React to WTA Gene Testing After Canadian Open Wins

Coco Gauff and Elena Rybakina addressed the Women's Tennis Association's new mandatory SRY gene testing policy following their respective victories in Toronto.

Coco Gauff secured her opening-match victory at the Canadian Open in Toronto by defeating Kayla Day on Wednesday. Following the match, the two-time Grand Slam champion addressed the Women's Tennis Association's (WTA) recent implementation of a one-off mandatory gene-testing policy. This regulation, introduced last month, serves as a mandatory prerequisite for any athlete intending to compete at the 2028 Los Angeles Olympics. The screening specifically targets the SRY gene, a DNA segment typically found on the Y chromosome that initiates male sex development and the formation of testes.

Key details

World No. 2 Elena Rybakina also progressed on Wednesday after a victory over Daria Kasatkina. Rybakina shared her perspective on the new protocols, noting that while the tour functioned adequately without such measures previously, she would follow the established rules. The WTA maintains that this policy aims to distinguish biological sex from gender identity, asserting that the framework does not intend to undermine the dignity of any individual competitor. Despite these official justifications, Gauff voiced concerns that the policy is being weaponized to foster animosity toward the trans community.

The WTA’s decision to mandate genetic screening aligns with protocols already utilized by international governing bodies in boxing, skiing, and track and field. This one-time requirement applies to every player seeking eligibility for the 2028 Olympic Games. Gauff highlighted a significant lack of transparency during the rollout, mentioning that several professional peers remained unaware of the mandate until the public announcement was finalized. The American athlete stressed her commitment to fairness in women’s athletics while simultaneously condemning the politicized rhetoric surrounding the current debate.

During a press conference at 11:40 AM ET on August 6, 2026, Gauff provided a detailed response regarding the intersection of sports governance and social consequences. She explicitly stated her opposition to the "attack" the ruling has facilitated, particularly by those using the policy as a platform to target transgender individuals. At this stage, the WTA has not disclosed data regarding the number of transgender women currently competing on the professional tour or at the Olympic level.

Latest developments

While the governing body argues that the screening protects the integrity of the female category, the mandate has drawn scrutiny from human rights experts and various activist organizations. The SRY gene test focuses exclusively on biological markers rather than an individual's self-identified gender, a distinction the WTA claims is fundamental to its competitive framework. Rybakina reiterated that although she views the tests as largely unnecessary for the sport's current climate, players will comply with the governing body's directives to maintain their standing for upcoming international tournaments.

The implementation of these tests marks a shift in how the WTA manages eligibility, moving toward a model that mirrors high-impact physical sports. Gauff noted that the timing of the announcement felt abrupt to many in the locker room. The policy requires players to undergo the screening just once in their career to satisfy the Olympic criteria. This specific genetic marker was chosen because it is the primary factor in determining the development of male physical characteristics during gestation.

Critics of the move suggest that the WTA is reacting to external political pressures rather than internal competitive issues. Gauff emphasized that the conversation has become increasingly polarized, moving away from the technicalities of sport and into the realm of social conflict. She remains one of the few high-profile players to speak extensively on the potential for these rules to be misinterpreted by the general public. The WTA has not yet responded to Gauff's specific comments regarding the lack of transparency in their communication strategy.

As the 2028 Los Angeles Olympics approach, the impact of this policy on player participation remains to be seen. The WTA has clarified that the results of these tests will be handled with strict confidentiality to protect player privacy. However, the requirement remains a non-negotiable step for any woman seeking to represent her country on the Olympic stage. Rybakina concluded her remarks by stating that the focus should remain on the tennis, even as administrative changes continue to reshape the professional landscape.